Material offerings

Disclaimer

Select the country in which you reside:

Select the country in which you are currently physically present:

This section of XVIVO Perfusion AB's website contains information relating to contemplated private placement of new shares in XVIVO Perfusion AB. This information may not be accessed by residents of certain countries based on applicable securities law regulations.

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WHOLLY OR PARTLY, IN THE United States of America, Australia, CANADA, New Zealand, Singapore, Hong Kong, Japan, South Africa, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW.

This website and the information contained herein is not intended for, and may not be accessed by, or distributed or disseminated to, persons resident or physically present in the United States of America (the "United States"), Australia, Canada, New Zealand, Singapore, Hong Kong, Japan, South Africa, South Korea and do not constitute an offer to sell or the solicitation of an offer to purchase or acquire, any securities of XVIVO Perfusion AB in any of the above mentioned jurisdictions or in any other jurisdiction in which such offer or solicitation would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. The securities of XVIVO Perfusion AB referred to on this website have not been, and will not be, registered under the Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act.

The securities of XVIVO Perfusion AB have also not been and will also not be registered under the applicable securities laws of Australia, Canada, Hong Kong, Japan, New Zealand, Singapore or South Africa and, subject to certain exemptions, may not be offered or sold in or into or for the account or benefit of any person having a registered address in, or located or resident in, Australia, Canada, Hong Kong, Japan, New Zealand, Singapore or South Africa. There will be no public offer of the securities of XVIVO Perfusion AB in the United States, Australia, Canada, Hong Kong, Japan, New Zealand, Singapore or South Africa..

Subject to certain exceptions, the information contained in this section of the Company’s website is directed only at and may only be communicated to persons in the EEA who are "qualified investors" within the meaning of Regulation (EU) 2017/1129. In addition, in the UK, the information contained in this section of the Company’s website is directed only at and may only be communicated to persons who are "qualified investors" within the meaning of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, who are also (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), or (ii) high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as "relevant persons").

Access to the information and documents contained on the following websites may be illegal in certain jurisdictions, and only certain categories of persons may be authorized to access such information and documents.

All persons residing outside of the above mentioned jurisdictions who wish to access the documents contained on this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website, or require registration or approval for any acquisition of securities by them. XVIVO Perfusion AB assumes no responsibility if there is a violation of applicable law and regulations by any person.

If you are not permitted to view materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this website.

By clicking "Yes", you confirm and certify that:

• You are not a resident of or physically present in any of the above jurisdictions or any other restricted jurisdiction; and
• You are either:
  • (a) a resident of, or physically present in, Sweden;
  • (b) if resident or physically present in a Member State of the European Economic Area other than Sweden, a qualified investor as defined in Regulation (EU) 2017/1129 of the European Parliament and of the Council; or
  • (c) otherwise authorized to access this information pursuant to applicable laws or regulations.

I have read, understand and agree to comply with all of the restrictions set forth above.